Literature DB >> 2001017

The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans.

J E Caldwell1, M J Laster, T Magorian, T Heier, N Yasuda, D P Lynam, E I Eger, R B Weiskopf.   

Abstract

The neuromuscular effects of desflurane administered alone were studied in ten healthy human volunteers aged 20-27 yr. Also, the dose-response relationships of pancuronium and succinylcholine in surgical patients during anesthesia with desflurane (n = 13) were compared to those during isoflurane anesthesia (n = 14). In the volunteers, we measured the mechanical response of the adductor pollicis muscle to stimulation of the ulnar nerve in a train-of-four (TOF) sequence at 2 Hz and at tetanic frequencies of 50, 100, and 200 Hz, each administered for 5 s. Amplitudes of the first response (T1) in each TOF sequence and the ratios of the fourth TOF response (T4) to the first were similar at 3, 6, and 9% desflurane and decreased significantly only at 12% (P less than 0.05). Desflurane concentrations of 3-12% caused tetanic fade (greater than 10% decrement in amplitude) at 50, 100, and 200 Hz. The addition of N2O and the duration of anesthetic exposure did not alter desflurane's neuromuscular effects. The only neuromuscular variable influenced by CO2 was T1 amplitude, which decreased as arterial CO2 tension (PaCO2) increased. The doses of pancuronium that depressed T1 amplitude by 50% (ED50) were similar during anesthesia with 1.25 MAC desflurane, 10.5 +/- 2.8 micrograms/kg (mean +/- SD) and 1.25 MAC isoflurane, 12.3 +/- 5.0 micrograms/kg. The ED50 doses of succinylcholine were similar during anesthesia with desflurane 132 +/- 76 micrograms/kg and isoflurane 123 +/- 36 micrograms/kg. We conclude that desflurane significantly depresses neuromuscular function and augments the action of pancuronium and succinylcholine to a degree similar to that of isoflurane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001017     DOI: 10.1097/00000542-199103000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Neuromuscular pharmacology update.

Authors:  C Lee; S K Tsai; T Kubota
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

Review 2.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

3.  Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Authors:  T Morita; H Tsukagoshi; D Kurosaki; T Sugaya; D Yoshikawa; H Shimada
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

4.  Prolongation of the effect of a single dose of rocuronium in a patient with postpolio syndrome under desflurane anesthesia: a case report.

Authors:  Yukifumi Kimura; Yukie Nitta; Makiko Shibuya; Toshiaki Fujisawa
Journal:  J Dent Anesth Pain Med       Date:  2022-05-27

Review 5.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 6.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers.

Authors:  Ling Ye; Yunxia Zuo; Peng Zhang; Pingliang Yang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

8.  Effects of neuromuscular blockade on the surgical conditions of laparoscopic totally extraperitoneal inguinal hernia repair: a randomized clinical trial.

Authors:  M Fujimoto; F Kubota; H Kaneda
Journal:  Hernia       Date:  2022-02-02       Impact factor: 2.920

Review 9.  The clinical use of desflurane.

Authors:  E I Eger
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct

10.  Facial Nerve Monitoring under Different Levels of Neuromuscular Blockade with Cisatracurium Besilate in Parotid Tumour Surgery.

Authors:  Huimin Huang; Hong Jiang; Jinxing Liu; Jie Chen; Lin Qiu; Jiayi Wang; Wenhui Liu; Huan Chen
Journal:  Biomed Res Int       Date:  2021-07-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.